Amgen Inc. (NASDAQ:AMGN) Q4 2025 Earnings Call Transcript February 3, 2026 Amgen Inc. beats earnings expectations. Reported ...

Biotech company Amgen (NASDAQ:AMGN) in Q4 CY2025, with sales up 8.6% year on year to $9.87 billion. The company’s full-year ...

Amgen Inc. (NASDAQ:AMGN) is included among the 15 Best S&P 500 Dividend Stocks to Buy in 2026. On January 20, Bernstein ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common ...

You can't hold back time, but scientists believe they may finally be able to slow down ageing. In a revolutionary new field, they are testing drugs to help people live healthier - for longer.

The California-based biotech company's quarterly revenue rose 9% from a year earlier to $9.9 billion, which beat the average ...

Amgen Inc. reports fourth-quarter earnings today after the bell, putting the spotlight on how the $185.6 billion biotechnology giant plans to navigate a year marked by significant biosimilar ...

Looking ahead, Amgen issued 2026 guidance with revenue projected between $37.0 billion and $38.4 billion, compared to the consensus estimate of $37.1 billion. The company expects adjusted EPS of ...

For 25 years, Pew Research Center has tracked some of the biggest technological shifts in history. Note: We conducted polls via phone from 2000 to 2021; via web and mail in 2023; and via web, mail and ...

Robin has worked as a credit cards, editor and spokesperson for over a decade. Prior to Forbes Advisor, she also covered credit cards and related content for other national web publications including ...